Broker Center sponsored links

PREVIEW-LASIK industry braces for U.S. FDA meeting

Tue Apr 22, 2008 2:26pm EDT
 
Email | Print | | Reprints | Single Page
[-] Text [+]

* April 25 FDA advisory meeting on LASIK

* Industry wary of the outcome

* Patient stories to be heard

By Susan Heavey

WASHINGTON, April 22 (Reuters) - The laser eye surgery industry is steeling itself ahead of a Friday meeting expected to draw complaints from patients with blurred vision and other complications of a popular vision procedure.

Millions of patients have hailed the LASIK procedure for freeing them from glasses or contact lenses, but others have have become a vocal bloc railing against the surgery, citing everything from dry eye to surgical gaffes that left scarring.

Those complaints are set to be the focus of a U.S. Food and Drug Administration public meeting over patient satisfaction with LASIK, or laser-assisted in-situ keratomileusis.

The FDA is seeking the advice from a panel of outside experts about issues surrounding patients' experiences after the procedure.

"Industry is very concerned about this," said Glenn Hagele, head of a patient referral group, the Council for Refractive Surgery Quality Assurance.  Continued...

 

Help us advance this story. Provide relevant links or share your insights using our comment box. Please be considerate and help us by reporting any abuse you find. Reuters will delete comments that don't meet community standards.

Have a correction to this article? Email the editors

Featured Broker sponsored link

Editor's Choice

Photo

A selection of our best photos from the past 24 hours.  View Slideshow 

Most Popular on Reuters